Position in RGNX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$0
-$470,952 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Derivatives in RGNX
reported options exposure · as of Jun 30, 2026CallValue
$119,800
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $551,304,275 across 203 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,111 | $143,610,107 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,755 | $41,000,872 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
310,761 | $25,330,129 | |
| 4 | ARGX |
Argenx SE
|
19,499 | $18,090,587 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,890 | $17,426,626 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
203,557 | $15,932,406 | |
| 7 | RPRX |
Royalty Pharma plc
|
249,117 | $13,967,990 | |
| 8 | INSM |
INSMED Inc
|
128,553 | $13,706,320 |
All Filings in RGNX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,800 | 10,000 | Call | Sole | 2026-08-07 | |
| 2025-12-31 | $470,952 | 32,705 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $335,974 | 34,816 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $312,291 | 38,038 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $153,925 | 21,528 | Shares | Sole | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||